We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cancer Cells Persuaded to Self-Destruct

By Biotechdaily staff writers
Posted on 05 Sep 2002
A method has been developed to destroy cancer cells without damage to surrounding normal tissue through activation of double-stranded RNA (dsRNA)–dependent protein kinase (PKR), a potent growth inhibitory protein that is primarily activated in virally infected cells. More...
The method was described August 19, 2002, in the online edition of Nature Biotechnology.

PKR is activated as a result of viral invasion of normal cells. The activated protein triggers a process that results in death of the cell. Researchers at the Hebrew University of Jerusalem (Israel) developed a technique for inducing cancer cells that express mutated genes containing deletions or chromosomal translocations to activate PKR without activating it in normal cells. They found that antisense (AS) RNA complementary to fragments flanking the deletion or translocation could produce a dsRNA molecule of sufficient length (39-nucleotides) to activate PKR and induce cell death following hybridization with mutated but not wild-type mRNA.

This in vitro study was followed by experiments in mice with brain tumors. A lentiviral vector expressing the 39-nt AS sequence was found to strongly inhibit glioblastoma growth in mouse brain when injected after tumor cell implantation.

Professor Alex Levitzki of the department of biological chemistry of the Hebrew University cautioned that a great deal of laboratory and clinical work remains to be done before this technique will be able to be implemented in treatment of cancer patients.




Related Links:
Hebrew University of Jerusalem

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Hematology Consumables
Bioblood Devices
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.